Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.
Clinical trial NCT00801437 · COMPLETED
Trial details
- NCT number
- NCT00801437
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2008-10-01
- Primary completion
- 2009-06-01
- Enrollment
- 457
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.